Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter

NCT ID: NCT03987321

Last Updated: 2019-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

174 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-31

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to compare the Celect and Denali filters in terms of complicated filter retrieval and indwelling complications after a 2-month indwelling time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With anticoagulation being the standard treatment for deep venous thrombosis and pulmonary embolism, inferior vena cava filter placement plays an important role in patients who are amenable to anticoagulant therapy. Currently, many different types of retrievable filters are being used in clinical practice and the choice of the filters depends on operators' preference and institutional availability. Each filter has different designs to maximize retrievability and minimize indwelling complications. Up until now, the prior studies on the filter retrievability and indwelling complications have been retrospective in nature and had relatively long dwell times. Comparative data regarding the retrievability of the inferior vena cava filters may help to choose filter selection. Therefore, the aim of this trial is to compare two commonly used inferior vena cava filters (Denali and Celet filters)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Venous Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants are blinded to the filter type.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Denali Group

Those who received Denali filter placement

Group Type EXPERIMENTAL

Infrarenal vena cava filter placement

Intervention Type DEVICE

Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava. All other procedures are the same in both groups

Celect Group

Those who received Celect filter placement

Group Type EXPERIMENTAL

Infrarenal vena cava filter placement

Intervention Type DEVICE

Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava. All other procedures are the same in both groups

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Infrarenal vena cava filter placement

Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava. All other procedures are the same in both groups

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Patients who develop deep venous thrombosis and/or pulmonary embolism but are good candidates for anticoagulant therapy
* 2\. Inferior vena cava filtration before mechanical thrombectomy for deep venous thrombosis
* 3\. Prophylactic filter placement because of trauma or major surgery

Exclusion Criteria

* 1\. Sepsis
* 2\. Those who need permanent filter placement
* 3\. Congenital anatomical anomaly (IVC duplication, interrupted IVC)
* 4\. patients who need filter placement in the suprarenal inferior vena cava
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Radiology, Severance hospital, Yonsei College of Medicine

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Man Deuk Kim

Role: CONTACT

82-2-2228-7400

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Man Deuk Kim, MD, Ph.D

Role: primary

82-2-2228-7400

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-2019-0020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RIPT Feasibility Trial
NCT03070834 COMPLETED NA
Cook IVC Filter Study
NCT02046096 COMPLETED NA